Correlation Between Verona Pharma and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Passage Bio, you can compare the effects of market volatilities on Verona Pharma and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Passage Bio.
Diversification Opportunities for Verona Pharma and Passage Bio
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Verona and Passage is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Verona Pharma i.e., Verona Pharma and Passage Bio go up and down completely randomly.
Pair Corralation between Verona Pharma and Passage Bio
Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.75 times more return on investment than Passage Bio. However, Verona Pharma PLC is 1.33 times less risky than Passage Bio. It trades about 0.08 of its potential returns per unit of risk. Passage Bio is currently generating about 0.01 per unit of risk. If you would invest 1,246 in Verona Pharma PLC on August 30, 2024 and sell it today you would earn a total of 2,744 from holding Verona Pharma PLC or generate 220.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Verona Pharma PLC vs. Passage Bio
Performance |
| Timeline |
| Verona Pharma PLC |
| Passage Bio |
Verona Pharma and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verona Pharma and Passage Bio
The main advantage of trading using opposite Verona Pharma and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
| Passage Bio vs. Ikena Oncology | Passage Bio vs. Eliem Therapeutics | Passage Bio vs. HCW Biologics | Passage Bio vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |